More from Healthcare
Let's look over the charts and indicators.
The technical signals of the clinical-stage biotech company don't inspire confidence at this juncture.
TherapeuticsMD and Spark Networks are beaten-down names with recent buying interest from insiders in common.
There are a number of issues to consider from a trading standpoint as we start the week.